bpc-157 regulatory status not approved for human use fda Targets GLP-1 and Peptide Compounding, Advertising and 'Research Only' Labeling Exciting news for peptides coming
Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA panel to consider easing restrictions on peptide production : NPR Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

